Compugen Ltd
CGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001119774
In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Compugen Ltd changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 70 | 71 | +1 |
| Shares | 12.2M | 15.1M | +2.90M (+23.8%) |
| Value | $18.6M | $22.1M | +$3.41M (+18.3%) |
New holders (10)
Institutions that held Compugen Ltd at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ARK Investment Management LLCSuperinvestorARK Invest | 889,669 | $1.32M | 0.01% |
| Schnieders Capital Management LLC | 90,000 | $131.4K | 0.03% |
| Group One Trading, L.P. | 41,755 | $61.0K | 0.00% |
| Kestra Advisory Services, LLC | 41,500 | $60.6K | 0.00% |
| Calamos Wealth Management LLC | 29,500 | $43.1K | 0.00% |
| US Bancorp | 20,000 | $29.2K | 0.00% |
| Ieq Capital, LLC | 20,000 | $29.2K | 0.00% |
| Susquehanna International Group, LLP | 15,494 | $22.6K | 0.00% |
| GSG Advisors LLC | 10,245 | $13.1K | 0.00% |
| N.E.W. Advisory Services LLC | 400 | $584 | 0.00% |
Sold out (9)
Institutions that held Compugen Ltd at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Sphera Funds Management Ltd. | 177,094 | $271.0K |
| HRT Financial LP | 20,034 | $30.0K |
| Envestnet Asset Management Inc | 11,497 | $17.6K |
| Tower Research Capital LLC (TRC) | 10,740 | $16.4K |
| R Squared Ltd | 2,670 | $4.08K |
| Citigroup Inc | 922 | $1.41K |
| Barclays PLC | 560 | $857 |
| City State Bank | 200 | $306 |
| Modus Advisors, LLC | 28 | $43 |